Glioma remains one of the deadliest brain cancers, characterized by aggressive growth and limited treatment options. In a new study, researchers from Ningxia Medical University uncovered that choline ...

Scientist who established productive growth of HIV in an immortalised cell line, which led to the development of the UK’s first antibody test for the virus ...

Update will include new MRI analyses from the Phase 2b RewinD-LB clinical trial, status of global regulatory discussions, and finalized Phase 3 ...

UCB S.A. has key market opportunities in developing biopharmaceuticals addressing autoimmune and neurological diseases. Their focus on digital transformation, innovation, and tech partnerships aims to ...

A Purdue Research Foundation patent details the discovery of 5/5-5/6 bisaryl compounds acting as mitogen-activated protein kinase kinase kinase 7 (MAP3K7; TAK1) inhibitors reported to be useful for ...

Black Diamond Therapeutics, Inc. BDTX is building its equity story around a single, high-leverage asset: silevertinib, a ...

Sam Altman highlighted Paul Conyngham’s use of AI tools to design a cancer treatment for his dog Rosie, showing how AI can ...

Some cancer treatments fail not because the drugs were ineffective, but because tumours design a network to evade them.

The chemotherapy drug azacitidine, a frontline treatment for blood cancers such as myelodysplastic syndromes and acute ...

Introduction Skin rash is the most common adverse effect in patients with cancer receiving epidermal growth factor receptor inhibitors (EGFRIs), which can impair quality of life and lead to treatment ...